M1A.152

Clinical Causes: Prolonged occupational exposure to lead, such as in mining, construction, or manufacturing industries Chronic lead poisoning from contaminated water, paint, or imported products Long-term exposure with insufficient protective measures during handling lead materials Accumulation of lead in bones and tissues over time, disrupting uric acid metabolism

Key Symptoms: Persistent pain in the affected joint, especially during movement Swelling and redness around the left hip Limited range of motion due to joint stiffness Tenderness when touching the joint Possible formation of tophi, which are deposits of uric acid crystals General discomfort and fatigue in the affected limb

Diagnosis Path: Diagnosis involves a combination of medical history, physical examination, and laboratory tests. Healthcare providers often review exposure history to lead exposure sources. Blood and urine tests are conducted to measure lead levels. Joint aspiration may be performed to analyze synovial fluid for uric acid crystals. Imaging studies like X-rays can reveal joint damage or deposits typical of gout. Bone scans or other specialized imaging may support the diagnosis of lead accumulation in bones.

Treatment Protocols: Treatment approaches typically include eliminating exposure to lead, along with therapies aimed at managing gout symptoms. Chelation therapy may be used to remove excess lead from the body. Non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids can help reduce joint pain and inflammation. Uric acid-lowering medications, such as allopurinol, may be prescribed to decrease uric acid levels. Supportive care including rest, elevation of the joint, and physical therapy might be recommended to maintain joint function. Regular monitoring and follow-up are essential to prevent further joint damage and manage lead levels.